Cui Can, Li Hongxia, Bao Yiwen, Han Yingying, Yu Hongxiang, Song Huan, Zhang Bei
Department of Neurology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Department of Digestive Diseases, Huashan Hospital, Fudan University, Shanghai, China.
Front Neurol. 2024 Dec 20;15:1459576. doi: 10.3389/fneur.2024.1459576. eCollection 2024.
The role of N-methyl-D-aspartate receptor 2B (GRIN2B) single nucleotide polymorphisms (SNPs) in influencing the risk and progression of Parkinson's disease (PD) is still unclear. This study aimed to assess the impact of GRIN2B genotype status on PD susceptibility and symptom progression.
We enrolled 165 individuals with sporadic PD and 154 healthy controls, all of whom had comprehensive clinical data available at the start and during follow-up. We used chi-squared (χ) analysis to compare the allele and genotype frequency distributions between the patient and control groups. Linear mixed-effect models were employed to investigate the link between the GRIN2B genotype and the progression of motor and cognitive symptoms.
The prevalence of the GG + GT genotype and G allele was higher in patients compared to controls ( = 0.032 and = 0.001, respectively). Subgroup analysis revealed that the GG + GT genotype and G allele were significantly more frequently observed in late-onset PD (LOPD) patients compared to early-onset PD (EOPD) patients ( = 0.014 and = 0.035, respectively). Notably, individuals with the GG + GT genotype exhibited an estimated annual progression rate of 6.10 points on the Unified Parkinson's Disease Rating Scale (UPDRS), which is significantly higher than that of the TT genotype carriers. Furthermore, the GG + GT carriers showed a markedly rapid progression in rigidity. In addition, the GG + GT carriers demonstrated significantly faster progression rates in rigidity (1.83 points/year) and axial impairment (1.2 points/year) compared to the TT carriers. Notably, the GG genotype carriers exhibited a more rapid decline in recall function.
The GRIN2B rs219882 G allele is associated with increased PD susceptibility, particularly in LOPD. The carriers of the GG + GT genotype exhibited more rapid motor symptom progression, with a pronounced impact on rigidity and axial impairment.
N-甲基-D-天冬氨酸受体2B(GRIN2B)单核苷酸多态性(SNP)在影响帕金森病(PD)风险和进展中的作用仍不明确。本研究旨在评估GRIN2B基因型状态对PD易感性和症状进展的影响。
我们纳入了165例散发性PD患者和154名健康对照者,所有患者在研究开始时及随访期间均有完整的临床资料。我们使用卡方(χ)分析比较患者组和对照组之间的等位基因和基因型频率分布。采用线性混合效应模型研究GRIN2B基因型与运动和认知症状进展之间的联系。
与对照组相比,患者中GG + GT基因型和G等位基因的患病率更高(分别为= 0.032和= 0.001)。亚组分析显示,与早发性PD(EOPD)患者相比,晚发性PD(LOPD)患者中GG + GT基因型和G等位基因的观察频率显著更高(分别为= 0.014和= 0.035)。值得注意的是,GG + GT基因型个体在统一帕金森病评定量表(UPDRS)上的估计年进展率为6.10分,显著高于TT基因型携带者。此外,GG + GT携带者的僵硬进展明显更快。此外,与TT携带者相比,GG + GT携带者的僵硬(1.83分/年)和轴性损害(1.